Rebound Cases News Today

insight into former president trumps strategy in this ongoing back and forth over the documents kept at mar-a-lago. and the legal advice and from whom hes getting from conservative activist tom fitton. one person close to the former president said once trump took fittons advice, quote, it was all downhill from there. this was sources tell cnn trump and his allies have become increasingly concerned about the potential legal implications from all this. plus, president biden fresh off wha...

mill. a five-year communications major from arizona state, perfect, step right this way. youre now a barista in a strip mall. the whole thing is a scam obviously. think time-shares in cabo, but without the waterfront condos. we said all of this many times on the show. college debt is real, hurting young people, and theres no good reason for it. so when joe biden announced today that he plans to cancel some of that debt, the obvious response would be to celebrate the announcement, but w...

(CTN News) - The Food and Drug Administration (FDA) has granted full approval to Pfizer's antiviral Paxlovid for treating mild to moderate COVID-19 in

New research suggests that those infected more than once have an increased risk of developing long COVID and other health problems compared to those infected just once. But parsing out the extent of these risks – particularly with newer variants – is more complicated.

About 27% of people who get COVID-19 have a rebound of their symptoms, regardless of whether they took the antiviral treatment Paxlovid.

These rebound cases are among high-risk patients with moderate to mild symptoms who have taken a Paxlovid treatment.